bioAffinity Technologies Inc. (BIAF): Price and Financial Metrics

bioAffinity Technologies Inc. (BIAF): $2.91

0.08 (+2.83%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

D

Add BIAF to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#324 of 363

in industry

BIAF Price/Volume Stats

Current price $2.91 52-week high $3.62
Prev. close $2.83 52-week low $0.95
Day low $2.89 Volume 209,500
Day high $3.10 Avg. volume 180,642
50-day MA $2.03 Dividend yield N/A
200-day MA $1.68 Market Cap 33.51M

BIAF Stock Price Chart Interactive Chart >



BIAF Latest News Stream


Event/Time News Detail
Loading, please wait...

BIAF Latest Social Stream


Loading social stream, please wait...

View Full BIAF Social Stream

Latest BIAF News From Around the Web

Below are the latest news stories about BIOAFFINITY TECHNOLOGIES INC that investors may wish to consider to help them evaluate BIAF as an investment opportunity.

bioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of Directors

SAN ANTONIO, December 05, 2023--Jamie Platt, Ph.D., joins the bioAffinity Technologies Board of Directors

Yahoo | December 5, 2023

CMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024

SAN ANTONIO,, November 30, 2023--CMS has made a final determination for payment for CyPath® Lung, a noninvasive test for early-stage lung cancer, for the 2024 calendar year.

Yahoo | November 30, 2023

bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post

SAN ANTONIO, November 28, 2023--bioAffinity Technologies VP of Research David Elzi, Ph.D., named to post with the American Society for Cell Biology

Yahoo | November 28, 2023

bioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer Screening

SAN ANTONIO, Texas, November 15, 2023--bioAffinity Technologies today launched a campaign in partnership with the ACS to increase lung cancer screening in Texas.

Yahoo | November 15, 2023

bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update

SAN ANTONIO, November 14, 2023--bioAffinity Technologies reports third quarter 2023 financial results and provides business update.

Yahoo | November 14, 2023

Read More 'BIAF' Stories Here

BIAF Price Returns

1-mo 40.58%
3-mo 88.96%
6-mo 102.07%
1-year 60.77%
3-year N/A
5-year N/A
YTD 97.89%
2023 -8.09%
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!